Moderna: “Simultaneous Flu and COVID Vaccination a Shield for High-Risk Groups”

High Immune Response and Safety Confirmed in Simultaneous Vaccination Study,
,
,

Dr. Francesca Ceddia, Chief Medical Officer of Moderna, speaking at the press conference on the 30th
[Photo by Yoo Han-joo],
,
, ‘(Seoul=Yonhap News) Reporter Yoo Han-joo = Moderna stated on the 30th that “simultaneous vaccination with the flu vaccine and the Moderna vaccine can be an important strategy for protecting high-risk groups.”‘,
,
, ‘ Dr. Francesca Ceddia, Chief Medical Officer of Moderna, said at a press conference held at the Novotel Ambassador Seoul Gangnam this morning, “The Moderna COVID-19 vaccine has consistently demonstrated effectiveness and safety through more than 1 billion doses administered worldwide.”‘,
,
, ‘ Dr. Ceddia explained, “The simultaneous vaccination study of the flu vaccine and the Moderna vaccine confirmed high immunogenicity and safety similar to that of individual vaccinations,” and added, “(Simultaneous vaccination) is significant as an important strategy for protecting high-risk groups.”‘,
,
, ‘ Moderna’s COVID-19 vaccine has proven excellent effectiveness and safety through large-scale phase 3 clinical trials and extensive real-world evidence (RWE), the company reported.’,
,
, ‘ Notably, in those aged 65 and older, immune responses comparable to younger groups were observed, and a strong antibody response was induced when vaccinated with the Moderna vaccine regardless of previous vaccinations.’,
,
, ” The updated ‘Spikevax LP’ used this season is designed to induce a strong immune response against COVID-19 LP.8.1.”,
,
, ‘ Professor Lee Jae-gap from the Department of Infectious Diseases at Hallym University Kangnam Sacred Heart Hospital stated, “COVID-19 hospitalizations have been increasing for three consecutive months, with over 60% being aged 65 or older,” adding, “COVID-19 can lead to severe diseases as well as long-term aftereffects such as fatigue and cognitive decline, which can affect quality of life, thus annual new vaccinations are necessary to maintain immunity.”‘,
,
, ‘ Kim Sang-pyo, President of Moderna Korea, stated, “Moderna will prioritize protecting high-risk groups such as those aged 65 and older,” and added, “We will actively support the government and medical sites to ensure this season’s vaccination program proceeds smoothly.”‘,
,
, ” The government’s ’25-’26 season COVID-19 vaccination program will commence on the 15th of next month. Those aged 65 or older, immunocompromised individuals, and residents of infection-vulnerable facilities are strongly recommended to receive the COVID-19 vaccine, which is available for free.”,
,
, ‘ hanju@yna.co.kr’,
,
,